Table of Contents

1 Study Coverage

• 1.1 Keloid Treatment Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Keloid Treatment Market Size Growth Rate by Product
  • 1.4.2 Occlusive Dressing
  • 1.4.3 Compression Therapy
  • 1.4.4 Cryosurgery
  • 1.4.5 Excision
  • 1.4.6 Radiation Therapy
  • 1.4.7 Laser Therapy
  • 1.4.8 Interferon Therapy
  • 1.4.9 Intralesional Corticosteroid Injection
  • 1.4.10 Others
• 1.5 Market by End User
  • 1.5.1 Global Keloid Treatment Market Size Growth Rate by End User
  • 1.5.2 Hospitals
  • 1.5.3 Dermatology Clinics
  • 1.5.4 Ambulatory Surgical Centres
  • 1.5.5 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Keloid Treatment Market Size
  • 2.1.1 Global Keloid Treatment Revenue 2014-2025
  • 2.1.2 Global Keloid Treatment Sales 2014-2025
• 2.2 Keloid Treatment Growth Rate by Regions
  • 2.2.1 Global Keloid Treatment Sales by Regions
  • 2.2.2 Global Keloid Treatment Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Keloid Treatment Sales by Manufacturers
  • 3.1.1 Keloid Treatment Sales by Manufacturers
  • 3.1.2 Keloid Treatment Sales Market Share by Manufacturers
  • 3.1.3 Global Keloid Treatment Market Concentration Ratio (CR5 and HHI)
• 3.2 Keloid Treatment Revenue by Manufacturers
  • 3.2.1 Keloid Treatment Revenue by Manufacturers (2014-2019)
  • 3.2.2 Keloid Treatment Revenue Share by Manufacturers (2014-2019)
• 3.3 Keloid Treatment Price by Manufacturers
• 3.4 Keloid Treatment Manufacturing Base Distribution, Product Types
  • 3.4.1 Keloid Treatment Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Keloid Treatment Product Type
  • 3.4.3 Date of International Manufacturers Enter into Keloid Treatment Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Keloid Treatment Sales by Product
• 4.2 Global Keloid Treatment Revenue by Product
• 4.3 Keloid Treatment Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Keloid Treatment Breakdown Data by End User

6 North America

• 6.1 North America Keloid Treatment by Countries
  • 6.1.1 North America Keloid Treatment Sales by Countries
  • 6.1.2 North America Keloid Treatment Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Keloid Treatment by Product
• 6.3 North America Keloid Treatment by End User

7 Europe

• 7.1 Europe Keloid Treatment by Countries
  • 7.1.1 Europe Keloid Treatment Sales by Countries
  • 7.1.2 Europe Keloid Treatment Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Keloid Treatment by Product
• 7.3 Europe Keloid Treatment by End User

8 Asia Pacific

• 8.1 Asia Pacific Keloid Treatment by Countries
  • 8.1.1 Asia Pacific Keloid Treatment Sales by Countries
  • 8.1.2 Asia Pacific Keloid Treatment Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Keloid Treatment by Product
• 8.3 Asia Pacific Keloid Treatment by End User

9 Central & South America

• 9.1 Central & South America Keloid Treatment by Countries
  • 9.1.1 Central & South America Keloid Treatment Sales by Countries
  • 9.1.2 Central & South America Keloid Treatment Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Keloid Treatment by Product
• 9.3 Central & South America Keloid Treatment by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Keloid Treatment by Countries
  • 10.1.1 Middle East and Africa Keloid Treatment Sales by Countries
  • 10.1.2 Middle East and Africa Keloid Treatment Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Keloid Treatment by Product
• 10.3 Middle East and Africa Keloid Treatment by End User

11 Company Profiles

• 11.1 Novartis
  • 11.1.1 Novartis Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Novartis Keloid Treatment Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Novartis Keloid Treatment Products Offered
  • 11.1.5 Novartis Recent Development
• 11.2 Sensus
  • 11.2.1 Sensus Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Sensus Keloid Treatment Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Sensus Keloid Treatment Products Offered
  • 11.2.5 Sensus Recent Development
• 11.3 RXi
  • 11.3.1 RXi Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 RXi Keloid Treatment Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 RXi Keloid Treatment Products Offered
  • 11.3.5 RXi Recent Development
• 11.4 Sonoma
  • 11.4.1 Sonoma Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Sonoma Keloid Treatment Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Sonoma Keloid Treatment Products Offered
  • 11.4.5 Sonoma Recent Development
• 11.5 Perrigo
  • 11.5.1 Perrigo Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Perrigo Keloid Treatment Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Perrigo Keloid Treatment Products Offered
  • 11.5.5 Perrigo Recent Development
• 11.6 Bristol-Myers Squibb
  • 11.6.1 Bristol-Myers Squibb Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Bristol-Myers Squibb Keloid Treatment Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Bristol-Myers Squibb Keloid Treatment Products Offered
  • 11.6.5 Bristol-Myers Squibb Recent Development
• 11.7 Pacific World
  • 11.7.1 Pacific World Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Pacific World Keloid Treatment Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Pacific World Keloid Treatment Products Offered
  • 11.7.5 Pacific World Recent Development
• 11.8 Valeant
  • 11.8.1 Valeant Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Valeant Keloid Treatment Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Valeant Keloid Treatment Products Offered
  • 11.8.5 Valeant Recent Development
• 11.9 Revitol
  • 11.9.1 Revitol Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Revitol Keloid Treatment Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Revitol Keloid Treatment Products Offered
  • 11.9.5 Revitol Recent Development
• 11.10 Avita
  • 11.10.1 Avita Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Avita Keloid Treatment Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Avita Keloid Treatment Products Offered
  • 11.10.5 Avita Recent Development

12 Future Forecast

• 12.1 Keloid Treatment Market Forecast by Regions
  • 12.1.1 Global Keloid Treatment Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Keloid Treatment Revenue Forecast by Regions 2019-2025
• 12.2 Keloid Treatment Market Forecast by Product
  • 12.2.1 Global Keloid Treatment Sales Forecast by Product 2019-2025
  • 12.2.2 Global Keloid Treatment Revenue Forecast by Product 2019-2025
• 12.3 Keloid Treatment Market Forecast by End User
• 12.4 North America Keloid Treatment Forecast
• 12.5 Europe Keloid Treatment Forecast
• 12.6 Asia Pacific Keloid Treatment Forecast
• 12.7 Central & South America Keloid Treatment Forecast
• 12.8 Middle East and Africa Keloid Treatment Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Keloid Treatment Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

Keloid is an overgrowth of the scar tissues that develop from a wound. Keloid development usually happens after the wound has healed. Keloids grow beyond the border of a scar and develop into a lump. The cause of keloid development cannot be determined but it can develop after surgery, burn injury, piercing, trauma, acne, vaccination and other wounds or cuts. According to the National Institute of Health, keloid scars are commonly seen in people in the age group 10 to 30 years of age.
Excision treatment type segment is anticipated to reach a market value of US$ 1,172.1 Mn by 2025 end, expanding at a CAGR of 3.4% during the forecast period.
The global Keloid Treatment market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Keloid Treatment market based on company, product type, end user and key regions.

This report studies the global market size of Keloid Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Keloid Treatment in these regions.
This research report categorizes the global Keloid Treatment market by top players/brands, region, type and end user. This report also studies the global Keloid Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Novartis
Sensus
RXi
Sonoma
Perrigo
Bristol-Myers Squibb
Pacific World
Valeant
Revitol
Avita

Market size by Product
Occlusive Dressing
Compression Therapy
Cryosurgery
Excision
Radiation Therapy
Laser Therapy
Interferon Therapy
Intralesional Corticosteroid Injection
Others
Market size by End User
Hospitals
Dermatology Clinics
Ambulatory Surgical Centres
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Keloid Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Keloid Treatment market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Keloid Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Keloid Treatment submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Keloid Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Keloid Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.